A Case of Torsion Dystonia Treated with Orphenadrine

Benson P. F. (1960). Dystonia musculorum deformans presenting as spasmodic torticollis. Proc. roy. Soc. Med., 53, 951

Cronheim G. (1958). Pharmacologic observations with orphenadrine hydrochloride. J. Pharmacol. exp. Ther., 122, 16A

Davison C. Goodhart S. P. (1933). Dystonia musculorum deformans. Arch. Neurol. Psychiat. (Chicago), 29, 1108

Davison C. Goodhart S. P. (1938). Dystonia musculorum deformans. Arch. Neurol. Psychiat. (Chicago), 39, 939

De Maar E. W. (1956). Site and mode of action in the central nervous system of some drugs used in the treatment of Parkinsonism. Arch. int. Pharmacodyn., 105, 319

Doshay L. J. Constable K. (1957). Treatment of paralysis agitans with orphenadrine (disipal) hydrochloride. J. Amer. med. Ass., 163, 1352

Ensor C. R. Russell D. Chen G. (1954). A comparative study on some aspects of the pharmacology of diphenhydramine and chemically related compounds. J. Pharmacol. exp. Ther., 122, 318

Ford F. R. (1952). Diseases of the nervous system in infancy, childhood and adolescence. 3rd edition. Springfield, Ill.: Thomas

Gillhespy P. O. Ratcliffe A. H. (1955). Treatment of Parkinsonism with a new compound (B.S. 5930). Brit. med. J., 2, 352

Gillingham F. J. Watson W. S. Donaldson A. A. Naughton J. A. L. (1960). The surgical treatment of Parkinsonism. Brit. med. J., 2, 1395

Herz E. (1944). Dystonia. III. Pathology and conclusions. Arch. Neurol. Psychiat. (Chicago), 20, 20

Rosenfeld S. Nayampalli S. S. Goldner M. G. (1959). An evaluation of orphenadrine hydrochloride (disipal). J. Amer. Geriat. Soc., 7, 502

Walshe J. M. (1959). Current views on the pathogenesis and treatment of Wilson's disease. A. M. A. Arch. intern. Med., 103, 155